ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 186 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,318,000 | +13.7% | 45,695 | +25.4% | 0.00% | +100.0% |
Q3 2016 | $1,159,000 | +1.0% | 36,436 | +3.0% | 0.00% | 0.0% |
Q2 2016 | $1,148,000 | -86.0% | 35,369 | -88.0% | 0.00% | -90.9% |
Q1 2016 | $8,219,000 | -18.2% | 293,964 | +4.3% | 0.01% | -15.4% |
Q4 2015 | $10,048,000 | +8.4% | 281,840 | +0.5% | 0.01% | 0.0% |
Q3 2015 | $9,270,000 | -22.0% | 280,325 | -1.2% | 0.01% | -13.3% |
Q2 2015 | $11,881,000 | +65.9% | 283,682 | +29.1% | 0.02% | +66.7% |
Q1 2015 | $7,160,000 | +4.1% | 219,708 | +1.4% | 0.01% | 0.0% |
Q4 2014 | $6,881,000 | +27.2% | 216,723 | -0.8% | 0.01% | +12.5% |
Q3 2014 | $5,410,000 | -2.9% | 218,506 | -11.4% | 0.01% | +14.3% |
Q2 2014 | $5,572,000 | +6.1% | 246,650 | +14.3% | 0.01% | -12.5% |
Q1 2014 | $5,251,000 | +7.7% | 215,810 | +10.6% | 0.01% | +14.3% |
Q4 2013 | $4,875,000 | -11.3% | 195,083 | -2.5% | 0.01% | -22.2% |
Q3 2013 | $5,496,000 | +60.7% | 200,075 | +6.1% | 0.01% | +50.0% |
Q2 2013 | $3,421,000 | – | 188,486 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 25,819,768 | $972,631,000 | 7.89% |
SECTORAL ASSET MANAGEMENT INC | 822,392 | $30,980,000 | 3.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 240,773 | $9,068,000 | 3.53% |
HARVEY CAPITAL MANAGEMENT INC | 230,700 | $8,690,000 | 3.51% |
Palo Alto Investors LP | 1,641,030 | $61,818,000 | 2.60% |
GARRISON BRADFORD & ASSOCIATES INC | 73,350 | $2,763,000 | 2.31% |
EMORY UNIVERSITY | 52,977 | $1,996,000 | 1.58% |
Sivik Global Healthcare LLC | 120,000 | $4,520,000 | 1.54% |
Stanley-Laman Group, Ltd. | 143,876 | $5,420,000 | 1.45% |
ACUTA CAPITAL PARTNERS, LLC | 170,000 | $6,404,000 | 1.15% |